Daewoong Pharmaceutical and DNC Aesthetics announced on June 27 that they participated in the international aesthetic medicine conference 'AMUSE 2025,' held in Jakarta, Indonesia from June 17 to 22, where they presented an integrated treatment education program centered on their high-purity botulinum toxin product, Nabota.
The conference was organized by the Jakarta Science Academy and was attended by approximately 1,200 participants, including dermatologists and plastic surgeons.
Background Tae, director of It's Me Clinic Sejong, is conducting a live demonstration to share the latest medical techniques with Indonesian medical staff. Photo by Daewoong Pharmaceutical
During the event, Daewoong Pharmaceutical and DNC Aesthetics jointly operated an exhibition booth under the vision of "Move to NEW GEN," which aims to lead the new generation of the aesthetic industry.
Key aesthetic products from Daewoong and DNC Aesthetics were showcased, including the high-purity, high-quality botulinum toxin Nabota; the skin booster Facetem, composed of calcium hydroxyapatite (CaHA); the premium HA filler DCLASSY; and the polydioxanone (PDO) suture thread LUXX.
This event was led by KIIMOT (Korea-Indonesia Integrated Marketing Operation Taskforce), the newly launched integrated marketing organization of Daewoong Pharmaceutical and DNC Aesthetics. Based on the DEEP (Daewoong·DNC Medical-AEsthetic Expert Program) aesthetic education program, which consolidates the expertise of Daewoong and DNC Aesthetics, KIIMOT plans to further strengthen the integrated treatment education system for medical professionals in both Korea and Indonesia.
During the workshops and lecture sessions, Korean aesthetic experts shared their practical know-how with Indonesian medical staff. This included a live demonstration of lower face lifting and masseter hypertrophy procedures by Background Tae, director of It's Me Clinic Sejong, and a lecture on integrated treatment methods using Nabota and Facetem by Jeong Jaeyoon, director of Oaro Dermatology Nowon.
Background Tae stated, "The greatest advantage of Nabota is its rapid and long-lasting effect. It was a meaningful experience to share practical techniques utilizing Nabota with Indonesian medical professionals." Jeong Jaeyoon also commented, "It was valuable to share integrated treatment methods, which are key to a patient-tailored approach."
Ha Changwoo, head of the KIIMOT Aesthetic Business Division, emphasized, "We will continue to advance integrated treatment methods tailored to local trends in Indonesia, based on the unique pipeline of Daewoong and DNC Aesthetics, which meet global quality standards. Through the DEEP education program, we will support the systematic and sustainable development of local professional talent."
Meanwhile, Daewoong Pharmaceutical plans to officially launch Nabota in Indonesia in July and, under the leadership of KIIMOT, will continue local marketing focused on integrated treatments to raise awareness of its aesthetic pipeline, including Nabota and Facetem.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
